Navigation Links
Masimo Obtains CE Mark for SEDLine, Launches EEG-Based Brain Function Monitors in European Market
Date:8/24/2011

to differ materially and adversely from those expressed in our forward-looking statements as a result of various risk factors, including, but not limited to:  risks related to our belief that SEDLine facilitates more individualized titration of anesthesia that leads to patients receiving significantly less anesthetic and recovering faster, risks related to our assumptions of the repeatability of clinical results obtained, and risks related to our assumptions that SEDLINE will facilitate immediate detection of asymmetrical activity in all patients, as well as other factors discussed in the "Risk Factors" section of our most recent reports filed with the Securities and Exchange Commission ("SEC"), which may be obtained for free at the SEC's website at www.sec.gov. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct. All forward-looking statements included in this press release are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. We do not undertake any obligation to update, amend or clarify these statements or the "Risk Factors" contained in our most recent reports filed with the SEC, whether as a result of new information, future events or otherwise, except as may be required under the applicable securities laws.

Media Contacts:
Dana Banks
Phone: (949) 297-7348
Email: dbanks@masimo.com

Masimo, SET, Signal Extraction Technology, Improving Patient Outcome and Reducing Cost of Care ... by Taking Noninvasive Monitoring to New Sites and Applications, rainbow, SpHb, SpOC, SpCO, SpMet, PVI, rainbow Acoustic Monitoring, RRa, Radical-7, Rad-87, Rad-57, Rad-8, Rad-5, Pulse CO-Oximetry, Pulse CO-Oximeter,
'/>"/>

SOURCE Masimo
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Masimo Reports Second Quarter 2011 Financial Results
2. Masimo Announces Adoption of Stock Repurchase Program
3. Masimo Introduces Pronto-7™ Internationally and Lifts Voluntary Recall
4. Masimo to Report Second Quarter 2011 Financial Results after Market Close on August 9, 2011
5. Masimo and Dartmouth-Hitchcock Medical Center, First Cross-Industry Collaborative Honored With the Institute for Technology and Healthcare Clinical Application Award
6. Masimo Announces Rainbow Agreement with Philips
7. Masimo Pronto-7 Wins GOLD in the 2011 Medical Design Excellence Award Competition—the Premier Awards Program for the Medical Technology Community
8. Masimo Initiates Limited Market Release of E1, Single-Patient-Use Ear Sensor for Pulse Oximetry Monitoring
9. Masimo to Present at Goldman Sachs 32nd Annual Global Healthcare Conference
10. Masimo Reports First Quarter 2011 Financial Results
11. Masimo Launches New Reusable SpCO® Sensor with Improved Accuracy and Reliability in Low Oxygen Saturation and Elevated Methemoglobin States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... IRVINE, Calif. , Oct 22, 2014 ... Irvine, California , announced the receipt ... Small Business Innovation Research award (SBIR) from the National Institute of ... will fund the development of a Pan-HIV Protein Microarray ... the HIV-1 and HIV-2 subtypes and aid in the ...
(Date:10/22/2014)... Oct. 22, 2014  Paper Pak Industries, a ... APLS ® Body Guard Bio, a disposable, ... of bacteria and virus while protecting service providers ... Bio features a rugged, external nylon shell, watertight ... a leak-proof inner chamber that contains contaminated and ...
(Date:10/22/2014)... , Oct. 22, 2014  With a ... animal health medications, a Global Pharmaceutical and Biotech ... serialization technology and turnkey solution to protect their ... http://photos.prnewswire.com/prnh/20141021/153438 Photo - ... that was serialized and aggregated by the Xyntek ...
Breaking Medicine Technology:Biomarker Discovery Company, Antigen Discovery Inc., Awarded an NIH Phase I Small Business Innovation Research Grant to Develop a Pan-HIV Protein Microarray Chip 2New, State-Of-The-Art Body Bag Minimizes The Spread Of Bacteria And Virus 2Xyntek and Antares Serialization Solution Protects Pets Too! 2
... 30 Shire plc (LSE: SHP, ... announced findings at a major medical meeting from a Phase ... Daytrana ® (methylphenidate transdermal system) in adolescents aged 13 ... ). In addition, data regarding the pharmacokinetic profile ...
... , SAN DIEGO, Oct. 30 Gen-Probe Incorporated (Nasdaq: ... the Oppenheimer 20th Annual Healthcare Conference in New York on ... at the Lazard Capital Markets 6th Annual Healthcare Conference in ... Eastern time. The presentations are scheduled to be webcast ...
Cached Medicine Technology:Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD 2Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD 3Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD 4Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD 5Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD 6Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD 7Gen-Probe to Webcast Two Upcoming Investor Presentations 2
(Date:10/22/2014)... 22, 2014 Isabel Healthcare ... Health Professions (ASAHP) Conference on October 22-24 in Las ... participate in a panel discussion on Technology in Health ... Healthcare provides a diagnostic decision support tool and clinical ... skills of students and clinical learners. The Isabel tools ...
(Date:10/22/2014)... 2014 The Louis W. ... dedicated to distribute health information technology innovation to ... announced the development of six key guiding principles ... receiving healthcare. These are an expansion of the ... care that is respectful of and responsive to ...
(Date:10/22/2014)... Healthcare professionals who are looking for ... home or on-the-go via laptops, tablets or mobile ... premium Seminar-on-Demand CE courses. The new courses add ... hours of CE course offerings, allowing therapy ... such a diverse library, there’s something for everyone. ...
(Date:10/22/2014)... Akeso Biomedical, Inc. , a ... of bacterial infections, microbial biofilms, and chronic wounds, announced ... of directors. , Dr. Sinskey is ... Massachusetts Institute of Technology, or MIT. He has been ... Sinskey also holds positions as Co-Director of the Malaysia-MIT ...
(Date:10/22/2014)... HealthDay Reporter TUESDAY, Oct. ... in vitro fertilization (IVF) -- the incubation of embryos in ... device inside the vagina, new research suggests. Scientists from ... an INVOcell, might sharply cut costs for pricey IVF procedures ... accessible to those who don,t live near big-city assisted reproduction ...
Breaking Medicine News(10 mins):Health News:Isabel Healthcare to Participate in The Association of Schools of Allied Health Professions (ASAHP) 2014 Conference 2Health News:The Sullivan Institute for Healthcare Innovation Announces Release of Guiding Principles for Patient Experience-Centered Care 2Health News:Top Provider of Continuing Education at Home Releases 20 New Online Courses 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4
... Dendreon Corporation (Nasdaq:,DNDN) will release its third quarter financial ... conference call at 1:30,p.m. PT; 4:30 p.m. ET to review ... discussion may be obtained as follows: Time: ... November 15, 2007 Dial-in: ...
... 17th U.S. Surgeon General Richard H. Carmona Joins ... Says Report Findings May Open,Doors to Positive Change, ... and Prevent (STOP) Obesity Alliance today received a ... obesity in America:,unrealistic definitions of success, negative perceptions ...
... ARLINGTON, Va., Nov. 2 FBR Capital Markets,Corporation ... that,Christopher Warren has joined FBR Capital Markets as a ... group and will,focus on the medical device sector. ... research, and we,value the disciplined, rigorous method he,s developed ...
... dexamethasone contributes to a relentless fatigue and poor quality ... leukemia (ALL), according to a new study from St. ... could improve the quality of life for these children ... or eliminate these side effects. , The St. ...
... ... Options, WASHINGTON, Nov. 2 Today, the Society ... interventional cardiology, announced the,launch of Seconds Count, a patient ... authoritative resource about cardiovascular disease and,treatment. The program will ...
... Duane Reade Holdings, Inc. today,announced that on Thursday, November ... results before the open of the market. In ... conference,call on Thursday, November 8, 2007 at 10:00 a.m. ... Officer, and John Henry,Senior Vice President and Chief Financial ...
Cached Medicine News:Health News:-Dendreon to Hold Conference Call on Thursday, November 15, 2007 at 4:30 PM ET- 2Health News:New Academic Analysis Identifies Three Barriers to Achieving Healthy and Achievable Policies to Combat Obesity in America 2Health News:New Academic Analysis Identifies Three Barriers to Achieving Healthy and Achievable Policies to Combat Obesity in America 3Health News:FBR Capital Markets Hires Senior Healthcare Analyst 2Health News:St. Jude finds anti-leukemia drug increases patient fatigue 2Health News:New Web Site Helps Patients Navigate Heart Disease Treatment Options 2Health News:New Web Site Helps Patients Navigate Heart Disease Treatment Options 3
Provides extended cold therapy to the shoulder area for acute, chronic, or post-surgical applications. The DuraKold products can help reduce pain, edema, and speed recovery....
Provides continuous cold therapy to the knee area for acute, chronic, or post-surgical applications. Cryotherapy can reduce pain, swelling and facilitate faster rehabilitation....
... Halo™ was designed in 1988 as an attachment ... patient, it greatly restricts rotation of the cervical ... Halo can be removed while allowing the Collar ... used in conjunction with the Philadelphia Stabilizer attachment., ...
... cold therapy Gel Pad. Our Gel Pad helps ... to reduce swelling and /or hot therapy to ... order hot and cold therapy gel pad, place ... suspenders can be added to each support upon ...
Medicine Products: